Update: 05.11.2024
Last week: 43 week 2024 (21.10.2024 - 27.10.2024)
Last full month: September 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 10 618 | -1.5% | 13.2% | -0.3 | 18 467 384 | -0.3% | 8.7% | -0.1 | 0.5% |
| MoM | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| YTD | 333 000 | 23.4% | 12.1% | 3.2 | 677 440 928 | 33.0% | 9.3% | 1.9 | -9.1% |
| MAT | 403 934 | 24.3% | 11.7% | 2.8 | 824 901 189 | 35.7% | 9.2% | 1.7 | -5.5% |
| BRAINMAX | |||||||||
| WoW | 2 623 | -3.0% | 100.0% | 0 | 8 855 620 | -1.0% | 100.0% | 0 | -3.0% |
| MoM | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| YTD | 59 589 | 68.4% | 100.0% | 0 | 208 764 990 | 72.6% | 100.0% | 0 | 68.4% |
| MAT | 70 856 | 73.3% | 100.0% | 0 | 248 837 456 | 79.6% | 100.0% | 0 | 73.3% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 117 | -2.5% | 46.6% | 1 | 46 751 653 | -1.9% | 37.9% | 0.6 | -4.6% |
| MoM | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| YTD | 701 354 | -4.8% | 45.2% | 0.4 | 2 201 615 823 | -3.0% | 37.0% | -2.8 | -5.7% |
| MAT | 833 514 | -2.4% | 45.3% | 0.5 | 2 623 614 418 | 0.6% | 37.3% | -2.5 | -3.4% |
| MIGRENIUM | |||||||||
| WoW | 9 194 | -1.6% | 0.4% | 0 | 3 125 368 | -1.8% | 0.5% | 0 | -0.8% |
| MoM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| YTD | 486 407 | -10.9% | 0.5% | -0.1 | 153 546 285 | 51.4% | 0.7% | 0.2 | 6.4% |
| MAT | 582 058 | -11.7% | 0.5% | -0.1 | 174 795 341 | 43.6% | 0.6% | 0.1 | 9.2% |
| MODELAX-N | |||||||||
| WoW | 27 662 | 1.1% | 19.8% | -0.1 | 13 159 233 | 1.1% | 13.1% | 0 | 1.5% |
| MoM | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| YTD | 1 217 532 | 28.6% | 22.2% | 3.4 | 536 150 871 | 77.2% | 14.3% | 3.9 | 8.8% |
| MAT | 1 438 540 | 34.2% | 21.4% | 3.6 | 616 370 170 | 78.7% | 13.6% | 3.6 | 11.9% |
| REDUXIN | |||||||||
| WoW | 10 404 | -7.2% | 32.1% | -0.9 | 54 074 946 | -4.8% | 43.9% | -0.6 | -4.6% |
| MoM | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| YTD | 509 354 | -7.0% | 32.8% | -0.5 | 2 703 575 179 | 11.8% | 45.4% | 3 | -5.7% |
| MAT | 599 343 | -5.3% | 32.6% | -0.7 | 3 158 013 267 | 14.6% | 44.9% | 2.8 | -3.4% |
| REDUXIN FORTE | |||||||||
| WoW | 3 137 | -8.7% | 9.7% | -0.4 | 13 781 632 | -4.5% | 11.2% | -0.1 | -4.6% |
| MoM | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| YTD | 141 104 | 1.4% | 9.1% | 0.6 | 607 732 970 | 12.6% | 10.2% | 0.7 | -5.7% |
| MAT | 167 993 | 4.5% | 9.1% | 0.7 | 721 361 897 | 15.9% | 10.3% | 0.8 | -3.4% |
| SALVISAR | |||||||||
| WoW | 14 468 | 6.1% | 1.8% | 0.1 | 6 378 780 | 6.3% | 1.6% | 0.1 | 0.7% |
| MoM | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
| YTD | 443 563 | 7.0% | 1.4% | 0.1 | 183 561 727 | 34.8% | 1.2% | 0.2 | -2.5% |
| MAT | 527 272 | -2.1% | 1.3% | 0 | 211 145 447 | 17.8% | 1.2% | 0 | 0.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 333 000 | 23.4% | 12.1% | 3.2 | 677 440 928 | 33.0% | 9.3% | 1.9 | -9.1% |
| BRAINMAX | 59 589 | 68.4% | 100.0% | 0 | 208 764 990 | 72.6% | 100.0% | 0 | 68.4% |
| GOLDLINE PLUS | 701 354 | -4.8% | 45.2% | 0.4 | 2 201 615 823 | -3.0% | 37.0% | -2.8 | -5.7% |
| MIGRENIUM | 486 407 | -10.9% | 0.5% | -0.1 | 153 546 285 | 51.4% | 0.7% | 0.2 | 6.4% |
| MODELAX-N | 1 217 532 | 28.6% | 22.2% | 3.4 | 536 150 871 | 77.2% | 14.3% | 3.9 | 8.8% |
| REDUXIN CAPS | 509 354 | -7.0% | 32.8% | -0.5 | 2 703 575 179 | 11.8% | 45.4% | 3 | -5.7% |
| REDUXIN FORTE | 141 104 | 1.4% | 9.1% | 0.6 | 607 732 970 | 12.6% | 10.2% | 0.7 | -5.7% |
| SALVISAR | 443 563 | 7.0% | 1.4% | 0.1 | 183 561 727 | 34.8% | 1.2% | 0.2 | -2.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 403 934 | 24.3% | 11.7% | 2.8 | 824 901 189 | 35.7% | 9.2% | 1.7 | -5.5% |
| BRAINMAX | 70 856 | 73.3% | 100.0% | 0 | 248 837 456 | 79.6% | 100.0% | 0 | 73.3% |
| GOLDLINE PLUS | 833 514 | -2.4% | 45.3% | 0.5 | 2 623 614 418 | 0.6% | 37.3% | -2.5 | -3.4% |
| MIGRENIUM | 582 058 | -11.7% | 0.5% | -0.1 | 174 795 341 | 43.6% | 0.6% | 0.1 | 9.2% |
| MODELAX-N | 1 438 540 | 34.2% | 21.4% | 3.6 | 616 370 170 | 78.7% | 13.6% | 3.6 | 11.9% |
| REDUXIN CAPS | 599 343 | -5.3% | 32.6% | -0.7 | 3 158 013 267 | 14.6% | 44.9% | 2.8 | -3.4% |
| REDUXIN FORTE | 167 993 | 4.5% | 9.1% | 0.7 | 721 361 897 | 15.9% | 10.3% | 0.8 | -3.4% |
| SALVISAR | 527 272 | -2.1% | 1.3% | 0 | 211 145 447 | 17.8% | 1.2% | 0 | 0.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 10 618 | -1.5% | 13.2% | -0.3 | 18 467 384 | -0.3% | 8.7% | -0.1 | 0.5% |
| BRAINMAX | 2 623 | -3.0% | 100.0% | 0 | 8 855 620 | -1.0% | 100.0% | 0 | -3.0% |
| GOLDLINE PLUS | 15 117 | -2.5% | 46.6% | 1 | 46 751 653 | -1.9% | 37.9% | 0.6 | -4.6% |
| MIGRENIUM | 9 194 | -1.6% | 0.4% | 0 | 3 125 368 | -1.8% | 0.5% | 0 | -0.8% |
| MODELAX-N | 27 662 | 1.1% | 19.8% | -0.1 | 13 159 233 | 1.1% | 13.1% | 0 | 1.5% |
| REDUXIN CAPS | 10 404 | -7.2% | 32.1% | -0.9 | 54 074 946 | -4.8% | 43.9% | -0.6 | -4.6% |
| REDUXIN FORTE | 3 137 | -8.7% | 9.7% | -0.4 | 13 781 632 | -4.5% | 11.2% | -0.1 | -4.6% |
| SALVISAR | 14 468 | 6.1% | 1.8% | 0.1 | 6 378 780 | 6.3% | 1.6% | 0.1 | 0.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| BRAINMAX | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| GOLDLINE PLUS | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| MIGRENIUM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| MODELAX-N | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| REDUXIN CAPS | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| REDUXIN FORTE | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| SALVISAR | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
*****
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs